7 results
To evaluate the safety and performance of the TriCinch System* in the treatment of functional tricuspid regurgitation
To quantify the role of different abnormal loading conditions on atrial and ventricular electropathology in paediatric patients with CHD.
The primary objective of this study is to compare overall survival (OS) in patients with progressive PSMA-positive mCRPC who receive 177Lu-PSMA-617 in addition to best supportive/best standard of care versus patients treated with best supportive/…
to demonstrate persistent atrial fibrillation is associated with endocardial and epicardial dissociation of the heart.
To elucidate the correlation between proteostasis marker levels in serum and atrial tissue, and initiation and progression of AF in patients.
The purpose of this study is to determine whether 177Lu-PSMA-617, given for 6 cycles at a dose of 7.4 Gigabecquerel (GBq) (200 Millicuries (mCi)) +/- 10%, improves the radiographic progression free survival (rPFS) or death compared to a change in…
The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patientswith mHSPC.In this study, the SoC is defined as a combination of Androgen…